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Anabolic steroid use in the sporting arena is well
recognised,10 however, there appears to be increas-
ing numbers of people using these drugs for aes-
thetic reasons. Worryingly, the profile of the users
not only crosses social boundaries, but also age
groups, with children as young as 14 reporting there
use.5
As well as the side effects of the drugs,8 there are
the associated risks of infection associated with
needle sharing and poor injection technique. The
drugs themselves may be contaminated,2,12 the
illegal nature of there use necessitating illicit means
to obtain a supply.
We report on a case of bilateral deltoid abscesses
secondary to anabolic steroid use and the subse-
quent treatment. The literature pertaining to the
use of steroids and the reported clinical cases are
discussed.Case
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were fluctuant and exquisitely tender, measuring
4 cm  5 cm. The patient readily admitted to intra-
muscular steroid use, giving details of a 10-day
cycle, over which he took: 100 mg Viramone (testosterone propionate);
 300 mg Enathate (testosterone enathate);
 300 mg Deca–—duarabolin (nandrolone).
The patient was taken to theatre and both
abscesses incised and drained (Fig. 2). The wounds
were packed and antibiotics commenced consisting
of flucloxacillin (1 g QDS) and benzylpenicillin (1.2 g
QDS). Subsequent cultures showed a growth of Sta-
phylococcus aureus sensitive to flucloxacillin and
antibiotic therapy was therefore restricted to flu-
cloxacillin only.
The patient was followed up over a period of 2
months whilst dressing management was dealt with
by both district and clinic nursing staff. During his
follow-up the patient persisted in weight training,
altering his regime to accommodate his reduced
deltoid function. At discharge his wounds had
healed well and an agreed lifting strategy of low
weights and high reps was being utilised by the
patient. At no stage did the patient admit to either
needle or vial sharing, like wise the clinical incident
had not served to altered his intentions regards
further anabolic use.
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Figure 1 Pre-operative clinical appearance.
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Figure 2 Intra-operative drainage.Discussion
Anabolic steroid use for performance enhancing is
well recognised, and tested for by sporting bodies.10
With the increasing emphasis on the ‘body beauti-
ful’ concept, an increasing number of people are
turning to such drugs for aesthetic reasons.4,5 There
are no exact figures available on the scale of use,
but needle exchange programmes in many cities are
noticing that often the largest single group visiting
are intra-muscular steroid injectors,6 overtaking
opiate users. In some cases up to 60% of the client
base are anabolic steroid users.6 The Home Office
also estimates that as many as 42,000 people use the
drugs in the UK.1
Aworrying trend is the change in the profile of the
users. Steroid use is increasing among children and
adolescents as young as 14.5 Social groups are also
no boundary, with teachers, police officers and
office workers all admitting to anabolic abuse.
Schools are also noting usage among pupils.6 In a
study from the Children’s Hospital Boston, Massa-
chusetts4 they looked at a population of 6212 girls
and 4237 boys aged from 12 to 18 years old. 4.7% of
boys and 1.6% of girls used protein powders, crea-
tine, amino acids, beta-hydroxy-beta-methylbuty-rate, dehydroepiandrosterone, growth hormone or
anabolic/injectable steroids at least weekly. Boys
reading fashion or health and fitness magazines, and
girls who were trying to look like women in the
media, were significantly more likely than their
peers to use products to improve appearance or
strength.
There have been several reports of abscesses
related toanabolic steroid injection.2,7,9,11,12,13 Nee-
dle and vial sharing is commonplace and has often
been the attributed cause. Grace, Barker and Davies
reported needle sharing in a sample of 170 cases.5
Staphylococcal infections have been reported occur-
ring from needle sharing, or reusing,11 as well as
Streptococcus and atypical Mycobacteria.13
Another potential source of infection are the
drugs themselves. Steroids are banned under the
same Misuse of Drugs act that controls the supply of
restricted drugs such as heroin, cannabis and
cocaine. Users thus have to resort to illicit means
to obtain their supplies. As a result there are limited
guarantees that the product purchased is what it
says on the bottle. On the Internet there are a
variety of forums and resources where users
exchange information and advice to improve their
chances of success. Despite this, infections from
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smegmatis has been cultured from a veterinary
grade stanozolol that caused thigh abscesses in
two body builders.12 Likewise there has been a
report of a gluteal abscess caused by a drug con-
taminated with Pseudomonas.2Conclusion
Like most habits with associated risk, cessation of
the activity is the best way of reducing this risk. As
well as the associated side effects of testicular
atrophy, baldness and gynaecomastia,8 serious
infections can occur. These infections are often
secondary to needle sharing, contaminated product
and poor injection technique, and they should
therefore be preventable. Needle exchanges help
with this, and further patient education would also
be of benefit. The behaviour of anabolic drug users is
still open to further investigation. Having engaged in
an illegal activity they may be less inclined to seek
medical advice or aid, with potentially serious out-
comes. Also ‘muscle dysmorphia’ is accepted as a
psychological disorder, although it is still debated
whether it is a sub-category of body dysmorphic
disorders (such as anorexia nervosa), or more con-
sistent with an obsessive—compulsive disorder.3
Whilst not all steroid users will fall into this cate-
gory, some inevitably will, and as will require appro-
priate treatment for their condition. An abscess is
unlikely to be sufficient deterrent for such a patient.References
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